Internal Medicine, Endocrinology, Diabetes, & Metabolism · Scranton, PA
NPI
1104800341
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1800 Mulberry St
Scranton, PA, 18510
Phone (570) 703-7351
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
762 services
Medicare patients, 2024
304
Average age 73
Drug cost, 2024
$461K
1,058 prescriptions
Company payments, 2025
$1,236
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory D Borowski was code 99214 (office e&m - established), 383 times for 284 patients. In total Gregory D Borowski billed 762 services in 6 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 383 | 284 | $65.48 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 355 | 268 | $11.57 | $4,107 |
By year: 2022 $23K for 330 services; 2023 $28K for 441 services; 2024 $31K for 762 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 15 | 15 | $9.52 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory D Borowski prescribed most often to Medicare patients was Levothyroxine Sodium, with 137 prescriptions and refills. In total Gregory D Borowski wrote 1,058 Medicare prescriptions that cost $461K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 137 | 337 | 48 | $1,398 |
| Metformin Hcl Er Metformin Hcl | 58 | 151 | 21 | $419 |
| Ozempic Semaglutide | 57 | 68 | 19 | $62K |
| Jardiance Empagliflozin | 43 | 95 | 15 | $54K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 39 | 117 | 19 | $6,701 |
| Glimepiride Generic | 32 | 73 | 16 | $414 |
| Trulicity Dulaglutide | 32 | 43 | Under 11 | $38K |
| Mounjaro Tirzepatide | 29 | 29 | Under 11 | $29K |
| Cinacalcet Hcl Generic | 22 | 34 | Under 11 | $1,476 |
| Novolog Flexpen Insulin Aspart | 22 | 57 | 12 | $7,268 |
| Glipizide Er Glipizide | 20 | 56 | 12 | $716 |
| Glipizide Generic | 17 | 36 | Under 11 | $93.08 |
| Tresiba Flextouch U-100 Insulin Degludec | 17 | 21 | Under 11 | $8,929 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 17 | 23 | Under 11 | $954 |
| Metformin Hcl Generic | 16 | 33 | Under 11 | $307 |
Brand drugs: 480 claims; generic drugs: 521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory D Borowski $1,236 ($1,236 in general payments such as food, travel and fees) from 9 companies. The largest payer was Tandem Diabetes Care, Inc. with $335.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.